TRxADE HEALTH, Inc. /
Superlatus
TRxADE HEALTH completed its acquisition of Superlatus, Inc.
What happened
TRxADE HEALTH, Inc. completed its acquisition of Superlatus, Inc. through a merger, with Superlatus continuing as a wholly owned subsidiary. The filing says Superlatus shareholders received common stock at $7.30 per share as merger consideration.
The companies amended the merger agreement on Jan. 8, 2024, adjusting the merger consideration after Superlatus did not meet the post-closing condition of acquiring Prestige Farms, Inc.
The source
Everything on this page comes from the source below.
TRxADE HEALTH completed its acquisition of Superlatus, Inc.
This document is the source for the companies, stage, figure and people on this page.
Original filingUnlock with ProTimeline
Every date the source states, in order. Anything marked ahead is a target the source gives, not something that has happened.
Also stated
The source this page is built from.
Source-verifiedPublished by the source
The source this page is built from.
Source-verified
The same firms, in other deals
The firms' deal history and connections across other deals.
These firms' full profiles are part of Pro.
Request an inviteAlready invited? Sign in
Carrywatch Pro is by invitation. An invite lets you buy Pro.
By email · Weekly